C-Mer Eye Care Holdings (HKSE:03309) COGS-to-Revenue : 0.67 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings COGS-to-Revenue?

C-Mer Eye Care Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$655 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$974 Mil.

C-Mer Eye Care Holdings's COGS to Revenue for the six months ended in Dec. 2023 was 0.67.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. C-Mer Eye Care Holdings's Gross Margin % for the six months ended in Dec. 2023 was 32.74%.

C-Mer Eye Care Holdings COGS-to-Revenue Historical Data

The historical data trend for C-Mer Eye Care Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings COGS-to-Revenue Chart

C-Mer Eye Care Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

0.72

0.68

0.74

0.68

C-Mer Eye Care Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial													0.70	0.72	0.76	0.68	0.67

C-Mer Eye Care Holdings COGS-to-Revenue Calculation

C-Mer Eye Care Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1305.002	/	1923.964
	=	0.68

C-Mer Eye Care Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	654.891	/	973.701
	=	0.67

C-Mer Eye Care Holdings (HKSE:03309) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

C-Mer Eye Care Holdings's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	654.891 / 973.701
	=	32.74 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

C-Mer Eye Care Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines